Loading...

Benzimidazole-based FabI inhibitors: A promising novel scaffold for anti-staphylococcal drug development

The enoyl-ACP reductase (FabI) enzyme is a well validated target for anti-staphylococcal drug discovery and development. With the goal of finding alternate therapeutics for drug resistant strains of S. aureus, such as methicillin resistant S. aureus (MRSA), our previously published series of benzimi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:ACS Infect Dis
Main Authors: Mistry, Tina L., Truong, Lena, Ghosh, Arun K., Johnson, Michael E., Mehboob, Shahila
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659837/
https://ncbi.nlm.nih.gov/pubmed/27756129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.6b00123
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!